Product image of Kyleena (Levonorgestrel) supplied by GNH India

Kyleena

Active Ingredient:
Levonorgestrel
Origin:
EU

Kyleena (Levonorgestrel)

Levonorgestrel, the active ingredient in Kyleena, is a progestin intrauterine system presented as a 19.5 mg intrauterine device for intrauterine use. It prevents pregnancy and provides long‑acting reversible contraception for women of reproductive age. Kyleena is marketed in the European Union and is prescribed by qualified healthcare professionals.

GNH India supplies Kyleena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Bayer Spa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kyleena, a progestin intrauterine system, is used for contraception and related menstrual management.

  • Prevention of pregnancy: provides highly effective, long‑acting reversible contraception for up to five years.
  • Long‑acting reversible contraception: offers a convenient, hormone‑based method that does not require daily dosing.
  • Reduction of menstrual bleeding: may lessen menstrual blood loss and dysmenorrhea in some users.

How It Works

  • Kyleena releases levonorgestrel locally within the uterine cavity. The hormone thickens cervical mucus, impairs sperm motility and function, suppresses endometrial proliferation, and may inhibit ovulation. These combined actions create an environment that prevents fertilisation and implantation, thereby providing reliable contraception.

Side Effects

Common Side Effects

  • Irregular bleeding or spotting: unpredictable bleeding patterns, especially during the first months.
  • Pelvic pain or cramping: discomfort around the insertion site.
  • Headache: mild to moderate tension‑type headaches.
  • Breast tenderness: transient sensitivity or swelling.

Serious or Rare Side Effects

  • Uterine perforation: rare injury to the uterine wall during insertion.
  • Pelvic infection: signs include fever, foul discharge, or severe pain.
  • Expulsion of the device: the IUS may be partially or fully expelled, reducing efficacy.

Precautions & Warnings

Before insertion, several safety steps should be observed.

  • Confirm non‑pregnancy: verify the patient is not pregnant prior to placement.
  • Assess uterine anatomy: ensure appropriate uterine size and orientation for device fit.
  • Screen for active infection: avoid insertion in the presence of pelvic or cervical infection.
  • Counsel on bleeding changes: inform patients about possible irregular bleeding patterns.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Levonorgestrel released from Kyleena may interact with systemic medications that affect hormone metabolism.

Major Interactions (Avoid)

  • Rifampin and other strong enzyme inducers: may lower levonorgestrel levels and reduce efficacy.
  • Anticonvulsants such as carbamazepine or phenytoin: can increase hormone metabolism.
  • Antiretroviral drugs like efavirenz: may diminish contraceptive effectiveness.

Moderate Interactions (Monitor Closely)

  • Certain antibiotics (e.g., tetracycline): slight reduction in hormone activity, monitor bleeding.
  • Herbal supplements such as St. John’s wort: may induce hepatic enzymes, observe for breakthrough bleeding.
  • Hormonal therapies (e.g., combined oral contraceptives): generally safe but may be unnecessary when using Kyleena.

Frequently Asked Questions

Kyleena is a levonorgestrel‑releasing intrauterine system indicated for the prevention of pregnancy and provides long‑acting reversible contraception for up to five years. It is also used to reduce menstrual bleeding in some women.

Levonorgestrel released from Kyleena thickens cervical mucus, impairs sperm motility, suppresses the growth of the uterine lining, and may inhibit ovulation. These actions together prevent fertilisation and implantation, delivering reliable contraceptive protection.

The dose of Kyleena is fixed at 19.5 mg of levonorgestrel within the intrauterine system. The prescribing clinician determines suitability and timing of insertion; no patient‑adjusted dosing is required.

Kyleena is contraindicated in pregnancy (pregnancy category X) and should be removed if pregnancy occurs. For breastfeeding women, the device may be used after delivery, but clinicians should assess individual risk and discuss benefits versus alternatives.

To order Kyleena, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kyleena contains 19.5 mg of levonorgestrel, offering a slightly lower hormone dose than some alternatives such as Mirena. It provides up to five years of contraception, whereas higher‑dose devices may be approved for longer durations. Efficacy is comparable, but side‑effect profiles may differ slightly.

Kyleena should be stored at room temperature, below 25 °C, in its original sealed packaging. Protect the device from moisture and direct sunlight to maintain the integrity of the hormone reservoir until insertion.

Kyleena is inserted by a qualified healthcare professional into the uterine cavity using a sterile applicator. The procedure is performed in a clinical setting, often after a pelvic exam and may involve a brief local anaesthetic.

Serious risks include uterine perforation during insertion, pelvic infection, and expulsion of the device, which can reduce contraceptive effectiveness. Patients should seek immediate medical attention if they experience severe abdominal pain, fever, or suspect device displacement.

Kyleena is contraindicated in women who are currently pregnant, have known or suspected uterine anomalies, active pelvic infection, unexplained vaginal bleeding, or a history of uterine perforation. It should also be avoided in individuals with hypersensitivity to levonorgestrel or any component of the device.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.